A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

The new NCCN Guidelines for Patients®: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer is ...

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, "Toripalimab has made significant strides in its ...